Burning Rock Biotech Ltd
NASDAQ:BNR

Watchlist Manager
Burning Rock Biotech Ltd Logo
Burning Rock Biotech Ltd
NASDAQ:BNR
Watchlist
Price: 6.53 USD Market Closed
Market Cap: 67m USD

Wall Street
Price Targets

BNR Price Targets Summary
Burning Rock Biotech Ltd

There are no price targets for BNR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Burning Rock Biotech Ltd Competitors:
Price Targets
ACLX
Arcellx Inc
79% Upside
300142
Walvax Biotechnology Co Ltd
6% Upside
SPRY
ARS Pharmaceuticals Inc
135% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
37% Upside
VCEL
Vericel Corp
11% Upside
NBIX
Neurocrine Biosciences Inc
17% Upside
INCY
Incyte Corp
12% Upside
688278
Xiamen Amoytop Biotech Co Ltd
6% Downside

Revenue
Forecast

Revenue Estimate
Burning Rock Biotech Ltd

For the last 5 years the compound annual growth rate for Burning Rock Biotech Ltd's revenue is 21%. The projected CAGR for the next 3 years is 29%.

21%
Past Growth
29%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Burning Rock Biotech Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
47%
Average Beat

Net Income
Forecast

Net Income Estimate
Burning Rock Biotech Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
48%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BNR's stock price target?
Not Available

BNR doesn't have any price targets made by Wall Street professionals.

What is Burning Rock Biotech Ltd's Revenue forecast?
Projected CAGR
29%

For the last 5 years the compound annual growth rate for Burning Rock Biotech Ltd's revenue is 21%. The projected CAGR for the next 3 years is 29%.

Back to Top